Document is current
Any future updates will be listed below
-
Authors
Schröder, Dominik
Heinemann, Stephanie
Heesen, Gloria
Klawonn, Frank
Mikuteit, Marie
Niewolik, Jacqueline
Steffens, Sandra
Behrens, Georg
Jablonka, Alexandra
Müller, Frank
-
Clinical Trials BETA
Clinical trials referenced in this document:
drks00023972 at German Clinical Trials RegisterDocuments that mention this clinical trial
Who is pausing immunosuppressive medication for COVID-19 vaccination? Results of an exploratory observational trial
https://doi.org/10.1186/s40001-022-00727-7
-
Funding
Funding for this research was provided by:
European Fund for Regional Development (ZW7-85152953, ZW7-85152953, ZW7-85152953, ZW7-85152953, ZW7-85152953, ZW7-85152953, ZW7-85152953, ZW7-85152953, ZW7-85152953, ZW7-85152953)
Georg-August-Universität Göttingen
- License Information
-
More Information
Article History
Received: 12 November 2021
Accepted: 3 June 2022
First Online: 22 June 2022
Declarations
:
: All participants have given their written consent to participate in the study. Ethics vote was obtained from the Ethics Committee of the University Medical Center Göttingen (No. 29/3/21). The study is registered in the German Clinical Trials Register, an approved Primary Register in the WHO network (DRKS00023972).
: Not applicable.
: The authors affirm that they have no conflicts of interest.
